Study guide

9.4 Substance Use, Addictive, and Co-Occurring Disorder Indicators (DSM-5-TR)

ASWB Clinical Examination LCSW Licensure

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts & the 2026 Blueprint Change 1.2 The Three 2026 Content Areas 1.3 How to Use This Guide & Build Your Study Plan

2 Values & Ethics: Ethical Principles and Responsibilities

2.1 Confidentiality, HIPAA, and Protected Health Information 2.2 Informed Consent 2.3 Identifying and Resolving Ethical Dilemmas 2.4 Professional Values and Responsibilities to Clients, Colleagues, the Profession, and Society

3 Professional Wellness, Self-Care, and Development

3.1 Burnout, Secondary Trauma, Compassion Fatigue, and Self-Care 3.2 Professional Development Activities

4 Values & Ethics: Ethical Service Delivery

4.1 Protecting and Enhancing Client Self-Determination 4.2 Professional Boundaries, Dual Relationships, and Self-Disclosure 4.3 Mandatory Reporting and the Duty to Warn and Protect 4.4 Documentation and Maintaining Client Records 4.5 Responsible Billing, Managed Care, and Governmental Policy Impacts

5 Values & Ethics: Ethics in Practice Contexts

5.1 Death, Dying, and End-of-Life Ethical Issues 5.2 Ethical Issues in Clinical Supervision and Management 5.3 Termination, Electronic Practice, and Research Ethics

6 Diversity and Social Justice

6.1 Anti-Oppressive and Anti-Racist Practice 6.2 Social, Racial, Environmental, and Economic Justice 6.3 Culture, Race, Ethnicity, Gender, Sexual Orientation, and Intersectionality 6.4 Accessibility, Language, Neurodiversity, and Disability

7 Privilege, Exploitation, and Global Contexts

7.1 Privilege, Bias, Microaggressions, and Power Differentials 7.2 Exploitation, Trafficking, Truth and Reconciliation, and Global Contexts

8 Assessment and Planning: Assessment Concepts and Foundations

8.1 The Biopsychosocial Assessment Model 8.2 Typical and Atypical Development Across the Lifespan 8.3 Trauma, Stressors, Violence, and Crises 8.4 Family Dynamics and Interpersonal Relationships 8.5 Physical, Sexual, and Psychological Abuse and Neglect Across the Lifespan 8.6 Housing Instability, Homelessness, and Out-of-Home Displacement 8.7 Client Competence, Decision-Making Capacity, and Self-Monitoring

9 Assessment and Planning: DSM-5-TR Psychopathology Indicators Across the Lifespan

9.1 Mood and Anxiety Disorder Indicators (DSM-5-TR) 9.2 Trauma-, Stressor-, and Dissociative-Disorder Indicators (DSM-5-TR) 9.3 Psychotic, Bipolar, and Personality-Disorder Indicators (DSM-5-TR) 9.4 Substance Use, Addictive, and Co-Occurring Disorder Indicators (DSM-5-TR) 9.5 Eating, Neurodevelopmental, and Neurocognitive Disorder Indicators (DSM-5-TR)

10 Assessment and Planning: Assessment Methods and Techniques

10.1 Assessing Risk of Harm to Self and Others 10.2 Interviewing Principles and Techniques 10.3 The Mental Status Examination 10.4 Use of the DSM-5-TR in Clinical Assessment (Clinical-Specific)

11 Assessment and Planning: Assessment Practices, Treatment Planning, and Service Planning

11.1 Involving Clients in Problem Identification and Readiness for Change 11.2 Goal Planning, Treatment Planning, Triage, and Service Plans 11.3 Intervention Modality Selection and Cultural Considerations 11.4 Medication Effects, Client Readiness for Termination, and Community Resources

12 Intervention and Practice: Practice Concepts

12.1 Strengths-Based Practice, Empowerment, and the Helping Relationship 12.2 Interdisciplinary Collaboration and the Social Worker's Problem-Solving Role 12.3 End-of-Life Practice, Hospice, Palliative Care, and Parenting Capacity 12.4 Policies, Regulations, Legislation, and Developing Formal Documents

13 Intervention and Practice: Core Intervention Methods

13.1 Trauma-Informed Care 13.2 Verbal and Nonverbal Communication, Boundary Setting, and Emotional Regulation 13.3 Crisis Intervention, Anger Management, and Conflict Resolution 13.4 Evidence-Based Practices: CBT, DBT, MI, EMDR, and MBSR 13.5 Practice With Loss, Grief, Coping, and Stress-Management Skills

14 Intervention and Practice: Clinical and Specialty Intervention Methods

14.1 Engaging Voluntary and Involuntary Clients and Harm Reduction 14.2 Advocacy, Psychoeducation, Contracting, and Goal-Setting 14.3 Addiction Intervention Techniques and Case Management 14.4 Family Therapy Models, Interventions, and Approaches 14.5 Couples Interventions (Clinical-Specific), Group Work, and Service Networks

15 Intervention and Practice: Evaluation, Research, and Supervision

15.1 Evaluating the Progress and Effectiveness of Interventions 15.2 Program Evaluation, Agency Evaluation Methods, and Quality Assurance 15.3 Basic and Applied Research Design: Quantitative, Qualitative, Reliability, and Validity 15.4 Supervision and Consultation Models, Transference/Countertransference, and Fiscal Management

9.4 Substance Use, Addictive, and Co-Occurring Disorder Indicators (DSM-5-TR)

Key Takeaways Explain This Topic AI

DSM-5-TR substance use disorders use 11 criteria; severity is mild (2–3 criteria), moderate (4–5 criteria), and severe (6+ criteria), with craving added in DSM-5 and retained in the text revision.

Substance-specific intoxication and withdrawal syndromes exist for alcohol, opioids, stimulants, cannabis, nicotine, sedatives/hypnotics/anxiolytics, hallucinogens, and inhalants; cannabis withdrawal is recognized in DSM-5-TR.

Gambling disorder is the only behavioral addiction formally included in the DSM-5-TR Substance-Related and Addictive Disorders chapter, requiring 4+ criteria in a 12-month period.

Co-occurring disorders (SUD + mental illness) are the rule, not the exception; integrated treatment is the evidence-based standard, and the clinician must distinguish primary mental disorders from substance-induced mental symptoms by onset, persistence during abstinence, and course.

Ruling out substance-induced mood or psychotic symptoms requires evaluating whether symptoms began during intoxication/withdrawal and persist beyond the physiological window; symptoms lasting beyond a month of abstinence suggest a primary mental disorder.

Last updated: August 2026

9.4 Substance Use, Addictive, and Co-Occurring Disorder Indicators (DSM-5-TR)

Quick Answer: DSM-5-TR unified abuse and dependence into a single substance use disorder (SUD) with 11 criteria and three severity levels. The exam tests the 2-3 / 4-5 / 6+ severity cut-offs, common intoxication/withdrawal syndromes, gambling disorder as the lone behavioral addiction, and the integrated treatment principle for co-occurring disorders .

Why This Matters for the ASWB Clinical Exam

Substance use is present in a large share of clinical social work caseloads, and co-occurring mental illness is the norm. The exam repeatedly asks the clinician to (1) identify SUD severity from a vignette, (2) choose a validated screening tool, and (3) decide whether a mood or psychotic symptom is primary or substance-induced. Misjudging substance-induced symptoms leads to inappropriate diagnoses and treatment.

Substance Use Disorders: 11 Criteria and Severity

DSM-5-TR retains the single SUD diagnosis per substance, scored on 11 criteria organized in four groups:

Group Criteria

Impaired control Hazardous use; use in larger amounts or longer than intended; craving; failed attempts to cut down

Social impairment Failure to fulfill major role obligations; continued use despite social/interpersonal problems; activities given up

  • Risky use Continued use despite physical/psychological problems; tolerance*
  • Pharmacologic Withdrawal*; use to relieve or avoid withdrawal

*Tolerance and withdrawal do not count toward the diagnosis if the substance is taken solely under medical supervision.

Severity:

  • Mild : 2–3 criteria
  • Moderate : 4–5 criteria
  • Severe : 6 or more criteria

The early remission specifier applies when no criteria (except craving) have been met for at least 3 months but less than 12 months; sustained remission is 12 months or longer. A in a controlled environment specifier applies when the individual is in a locked setting or supervised setting with restricted access.

Intoxication and Withdrawal by Substance

The exam frequently tests substance-specific intoxication/withdrawal profiles:

Substance Intoxication Signs Withdrawal Signs

Alcohol Disinhibition, slurred speech, ataxia, impaired judgment Tremor, sweating, tachycardia, anxiety, seizures, delirium tremens (hallucinations, autonomic instability)

Opioids Pupillary constriction, sedation, slowed respiration Pupillary dilation, piloerection, rhinorrhea, lacrimation, diarrhea, muscle aches, yawning

Stimulants (cocaine, amphetamines) Pupillary dilation, tachycardia, hypertension, agitation, euphoria or dysphoria Fatigue, vivid unpleasant dreams, hypersomnia, increased appetite, depression

Cannabis Euphoria, conjunctival injection, increased appetite, dry mouth Irritability, anxiety, sleep difficulty, decreased appetite (recognized in DSM-5-TR)

Nicotine — Irritability, anxiety, craving, increased appetite, dysphoric mood

Sedatives/hypnotics/anxiolytics Sedation, ataxia, slurred speech Autonomic hyperactivity, tremor, insomnia, anxiety, seizures

  • Hallucinogens Perceptual changes, derealization, depersonalization Generally not recognized
  • Inhalants Belligerence, ataxia, nystagmus, euphoria Usually mild; not formally recognized
  • Screening Tools and SBIRT

AUDIT-C : a 3-item alcohol screen (frequency, typical quantity, heavy-episode frequency); a score of 4+ for men or 3+ for women indicates risky drinking warranting further assessment.

AUDIT : the full 10-item Alcohol Use Disorders Identification Test; a score of 8+ indicates hazardous use, 16+ likely dependence.

DAST-10 : Drug Abuse Screening Test for non-alcohol substances.

SBIRT ( Screening, Brief Intervention, Referral to Treatment ): the integrated public-health framework that the exam treats as the preferred model for universal screening and brief intervention in medical and behavioral health settings.

Gambling Disorder (Behavioral Addiction)

Gambling disorder is the only non-substance behavioral addiction formally included in the DSM-5-TR Substance-Related and Addictive Disorders chapter. It requires 4 or more of nine criteria in a 12-month period : preoccupation, tolerance (need to increase stakes), withdrawal (restlessness/irritability when cutting down), repeated unsuccessful attempts to stop, gambling to escape negative mood, chasing losses, lying to conceal, endangering relationships or opportunities, and relying on others for money. Severity is mild (4–5 criteria), moderate (6–7), severe (8–9). Internet gaming disorder remains in Section III as a condition for further study, not a formal diagnosis.

Co-Occurring Disorders and Integrated Treatment

Co-occurring disorders (also called dual diagnosis ) refer to the simultaneous presence of a substance use disorder and another mental disorder; prevalence is high (roughly half of those with severe mental illness also have a lifetime SUD). The exam expects the clinician to know that integrated treatment —simultaneous, coordinated care for both conditions by the same team or coordinated providers—is the evidence-based standard, not sequential or parallel treatment.

Primary vs. Substance-Induced Mental Symptoms

The key assessment task is distinguishing a primary mental disorder from a substance-induced mental disorder . DSM-5-TR indicators favoring a substance-induced disorder include:

Onset during or within a month of intoxication or withdrawal

Symptoms resolve with abstinence (typically within a month for alcohol- or stimulant-induced mood/psychotic symptoms)

Severity proportional to substance use

Indicators favoring a primary mental disorder (independent of substance use) include:

  • Onset before the SUD or during sustained abstinence
  • Symptoms persist beyond 1 month of abstinence
  • Family history of the primary mental disorder
  • Course that does not follow the substance use pattern

When unclear, DSM-5-TR allows a provisional diagnosis that is revised once a sufficient abstinence period clarifies the picture. The clinician should not withhold SUD treatment pending a definitive primary diagnosis; both are addressed concurrently under the integrated model.

Opioid Use Disorder Indicators

Opioid use disorder (OUD) has specific indicators the exam tests: craving, continued use despite overdose risk, recurrent overdose or near-overdose events, and pharmacologic indicators (tolerance requiring dose escalation, withdrawal when the opioid is unavailable). The 4 Ps for prenatal substance exposure (Parent, Partner, Past, Pregnancy) is a screening mnemonic for use during pregnancy; neonatal abstinence syndrome (neonatal opioid withdrawal syndrome) is a recognized consequence of prenatal opioid exposure.

A 44-year-old man presents with depressed mood and insomnia that began during a 2-week heavy alcohol binge and persist for 3 weeks after his last drink. He has no prior depression history. The most accurate DSM-5-TR assessment is alcohol-induced depressive disorder if symptoms resolve with continued abstinence; if they persist beyond 1 month of abstinence and meet MDD criteria, the diagnosis becomes co-occurring MDD and AUD .

DSM-5-TR Substance Use Disorder Severity by Criterion Count